Biomerica Statistics
NASDAQ: BMRAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
1.08-0.01 (-0.92%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Biomerica by the numbers
Biomerica has a market capitalization of $5.0 million based on 4.60M shares outstanding. With trailing EPS of $-1.64, Biomerica is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 42.3% below its 50-day average and 45.2% below its 200-day average.
Average daily trading volume is 72.95K shares, or about $78,787 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BMRA valuation vs. peer median
| Metric | BMRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.97M | $5.46M | -9% |
| Avg. volume | 72.95K | 195.12K | -63% |
Peer median across 8 companies: TRIB, CDIO, VNRX, QCLS, VRAX, IMDX, ICCC, NNNN.
Valuation
- Market cap
- $4.97M
- Forward P/E
- 2.77
- Price / sales (latest FY)
- 1.12
- EPS (TTM)
- $-1.64
- Shares outstanding
- 4.60M
Price and trading
- Previous close
- 1.09
- Open
- 1.13
- Day range
- 1.06 – 1.13
- 52-week range
- 1.01 – 2.94
- 52-week change
- -51.57%
- Beta
- —
- Volume
- 5.38K
- Average volume
- 72.95K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 26, 2025
Additional statistics
- Market Cap
- 4.97M
- Forward Pe
- 2.77
- Eps
- -1.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.94
- Week52 Low
- 1.01
- Avg Volume
- 72,951.00
- Shares Outstanding
- 4.60M
- Ma50
- 1.87
- Ma200
- 1.97
- Earnings Date
- Aug 26, 2025
- Pct From52w High
- -63.27%
- Pct From52w Low
- 6.93%